Back to search

Spain· ES:1201502001IP1

ROCLANDA 50 MICROGRAMOS/ML + 200 MICROGRAMOS/ML COLIRIO EN SOLUCION

A latanoprost and netarsudil product containing latanoprost + netarsudil, registered in Spain by Santen Oy. The same ATC class is registered in 14 of our 19 countries.

ATC S01EE51

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedROCLANDA 50 MICROGRAMOS/ML + 200 MICR…ATCS01EE51REGISTER NO.ES:1201502001IP1PACKS LISTED0CHECKEDJune 3, 2026

Where it is registered

Latanoprost and netarsudil is registered in 14 of 19 countries.

Countries holding a registration under ATC S01EE51 (latanoprost and netarsudil), each read from that country’s own register.

  • This record: Spain, from AEMPS CIMA (Spain)
  • 10 of them publish a price we can compare per daily dose

Latanoprost and netarsudil · ATC S01EE51

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

AEMPS CIMA (Spain)
Active substance
latanoprost + netarsudil
Manufacturer
Santen Oy
Country
Spain (ES)
ATC code
S01EE51
ATC class
Latanoprost and netarsudil
Defined daily dose
0.1 ml, AT
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
June 3, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Latanoprost and netarsudil in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All latanoprost and netarsudil products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Roclanda
  • Liechtenstein · Roclanda
  • Norway · Roclanda

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5fd04d91-c686-494c-8ef7-02000e5b9a98
GET /v1/drugs/5fd04d91-c686-494c-8ef7-02000e5b9a98?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Diagnóstico Hospitalario",
  "estado": "{\"aut\":1771425960000}",
  "nregistro": "1201502001IP1",
  "substance": "latanoprost + netarsudil"
}

See everything about latanoprost and netarsudil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.